Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a multi-drug combination that includes five different medications with complementary mechanisms of action for pain management: - **Lidocaine**: A local anesthetic that blocks sodium channels, preventing the generation and conduction of nerve impulses - **Morphine**: An opioid analgesic that binds to mu-opioid receptors in the central nervous system - **Paracetamol** (acetaminophen): A non-opioid analgesic that inhibits prostaglandin synthesis in the central nervous system - **NSAID** (non-steroidal anti-inflammatory drug): Reduces inflammation and pain by inhibiting cyclooxygenase enzymes - **Gabapentin**: An anticonvulsant that binds to voltage-gated calcium channels in the central nervous system This combination represents a multimodal approach to pain management, targeting different pain pathways simultaneously. The combination of lidocaine and morphine has been studied for pain management, though research suggests their combination may not always provide enhanced analgesia compared to lidocaine alone in certain applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + morphine + paracetamol + NSAID + gabapentin.